XML 74 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
¥ in Thousands, $ in Thousands
Class A Ordinary Shares [Member]
CNY (¥)
shares
Class C Ordinary Shares [Member]
CNY (¥)
shares
Additional paid-in capital [Member]
CNY (¥)
Statutory reserves [Member]
CNY (¥)
Retained earnings (Accumulated deficit) [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
CNY (¥)
Retained earnings (Accumulated deficit) [Member]
CNY (¥)
Accumulated other comprehensive income [Member]
CNY (¥)
Non-controlling interest [Member]
CNY (¥)
Cumulative Effect, Period of Adoption, Adjustment [Member]
CNY (¥)
USD ($)
CNY (¥)
Balance at Dec. 31, 2017 ¥ 640 ¥ 90 ¥ 3,456,307 ¥ 20,036   ¥ (3,316,715) ¥ 6,876 ¥ (1,275)     ¥ 165,959
Balance (in shares) at Dec. 31, 2017 | shares 34,206,939 4,708,415                  
Increase (Decrease) in Shareholders' Equity                      
Share-based compensation     8,121               8,121
Issuance of ordinary shares for restricted stock award ¥ 8   (8)                
Issuance of ordinary shares for restricted stock award (in shares) | shares 409,350                    
Issuance of ordinary shares ¥ 80   45,322               45,402
Issuance of ordinary shares (in shares) | shares 4,140,000                    
Foreign currency translation adjustment             1,304       1,304
Appropriation to statutory reserves       113   (113)          
Unrealized gain on investment, net of income taxes             125       125
Buy-outs of non-controlling interests     (2,619)         (1,885)     (4,504)
Deregistration of subsidiaries               (46)     (46)
Capital injection from minority shareholders               1,470     1,470
Net income/(loss)           44,990   (50)     44,940
Balance at Dec. 31, 2018 ¥ 728 ¥ 90 3,507,123 20,149   (3,271,838) 8,305 (1,786)     262,771
Balance (in shares) at Dec. 31, 2018 | shares 38,756,289 4,708,415                  
Increase (Decrease) in Shareholders' Equity                      
Share-based compensation     1,624               1,624
Issuance of ordinary shares for restricted stock award ¥ 2   (2)                
Issuance of ordinary shares for restricted stock award (in shares) | shares 101,910                    
Foreign currency translation adjustment             (2,924)       (2,924)
Appropriation to statutory reserves       36   (36)          
Unrealized gain on investment, net of income taxes             960       960
Non-controlling interests from new subsidiaries               1,285     1,285
Deregistration of subsidiaries               306     306
Net income/(loss)           (99,941)   (485)     (100,426)
Balance at Dec. 31, 2019 ¥ 730 ¥ 90 3,508,745 20,185   (3,371,815) 6,341 (680)     163,596
Balance (in shares) at Dec. 31, 2019 | shares 38,858,199 4,708,415                  
Increase (Decrease) in Shareholders' Equity                      
Share-based compensation     947               947
Issuance of ordinary shares for restricted stock award ¥ 1   (1)                
Issuance of ordinary shares for restricted stock award (in shares) | shares 50,001                    
Issuance of ordinary shares ¥ 63   35,515               35,578
Issuance of ordinary shares (in shares) | shares 3,015,076                    
Foreign currency translation adjustment             6,234       6,234
Unrealized gain on investment, net of income taxes             (474)       (474)
Deregistration of subsidiaries       (15,473)   15,473   (19)     (19)
Disposal of subsidiaries     (133) (502)   502         (133)
Net income/(loss)           (62,712)   (1,269)   $ (9,807) (63,981)
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2020         ¥ (594)       ¥ (594)    
Balance at Dec. 31, 2020 ¥ 794 ¥ 90 ¥ 3,545,073 ¥ 4,210   ¥ (3,419,146) ¥ 12,101 ¥ (1,968)   $ 21,633 ¥ 141,154
Balance (in shares) at Dec. 31, 2020 | shares 41,923,276 4,708,415